Skip to main content

Table 3 Univariate and multivariate analysis of DFS

From: Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA–IIA non-small cell lung cancer, a retrospective cohort study

Factors

Univariate analysis

Multivariate analysis

HR (95% CI)

P value

HR (95% CI)

P value

Gender

0.570 (0.458–0.709)

< 0.001

0.665 (0.496–0.892)

0.006

Age (year)

1.018 (1.007–1.029)

0.002

1.012 (1.001–1.023)

0.039

Tumor size (cm)

1.402 (1.278–1.538)

< 0.001

1.232 (1.089–1.394)

0.001

Smoking history

1.537 (1.258–1.877)

< 0.001

1.026 (0.780–1.348)

0.856

8th TNM stage

1.938 (1.570–2.393)

< 0.001

1.386 (0.997–1.928)

0.052

Visceral pleural invasion

1.333 (1.088–1.631)

0.005

1.053 (0.799–1.373)

0.709

Histology

 Squamous cell carcinoma

Ref

 

Ref

 

 Adenocarcinoma

0.782 (0.611–0.999)

0.049

1.222 (0.926–1.614)

0.157

 Others

0.946 (0.666–1.433)

0.905

1.179 (0.789–1.762)

0.422

Differentiation degree

1.559 (1.323–1.838)

< 0.001

1.338 (1.124–1.592)

0.001

Vascular invasion

1.982 (1.378–2.852)

< 0.001

1.474 (1.006–2.160)

0.047

Number of N2 LNs examined

 0–2

Ref

   

 3–5

0.627 (0.391–1.005)

0.052

0.730 (0.451–1.180)

0.199

 6–8

0.841 (0.545–1.297)

0.433

0.916 (0.590–1.423)

0.696

 9–11

0.737 (0.470–1.156)

0.183

0.826 (0.522–1.307)

0.413

 12–14

0.730 (0.463–1.151)

0.175

0.869 (0.545–1.385)

0.554

 > 14

0.759 (0.505–1.142)

0.186

0.665 (0.555–1.285)

0.431

Adjuvant chemotherapy

1.127 (0.858–1.481)

0.500

  

Thoracotomy or VATS

0.933 (0.763–1.141)

0.304

  

Number of N1 stations examined

 0–2

Ref

 

Ref

 

 3–5

0.654 (0.464–0.922)

0.015

0.640 (0.452–0.906)

0.012

 6–8

0.680 (0.486–0.949)

0.024

0.658 (0.469–0.924)

0.016

 9–11

0.595 (0.418–0.847)

0.004

0.585 (0.407–0.839)

0.004

 > 11

0.627 (0.445–0.884)

0.008

0.557 (0.391–0.793)

0.001